✦ LIBER ✦

Mo1218 Long-Term Outcomes of Certolizumab Pegol for Crohn's Disease: 7 Year Results From the PRECiSE 3 Study

✍ Scribed by Sandborn, William; Lee, Scott D.; Randall, Charles W.; Gutierrez, Alexandra; Schwartz, David A.; Ambarkhane, Sumeet; Kayhan, Cem; Pierre-Louis, Bosny; Kosutic, Gordana; Schreiber, Stefan; Lichtenstein, Gary R.

Book ID: 122260053
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 505 KB
Volume: 146
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(14)62133-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sa1274 Prior Use of Infliximab As a Pred

Sa1274 Prior Use of Infliximab As a Predictor of Long-Term Outcomes of Treatment With Certolizumab Pegol for Active Crohn's Disease: Analyses From the Precise 3 7-Year Study

✍ Rubin, David T.; Coarse, Jason; Kosutic, Gordana; Spearman, Marshall; Ambarkhane 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 128 KB

S1035 Certolizumab Pegol is Effective at

S1035 Certolizumab Pegol is Effective at Maintaining Response and Remission in Patients With Fistulising Crohn's Disease: 3-Year Results From the PRECiSE 3 Study

✍ Stefan Schreiber; Ian C. Lawrance; Ole O. Thomsen; Stephen B. Hanauer; Ralph Blo 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 80 KB

S1058 Certolizumab Pegol Improves Health

S1058 Certolizumab Pegol Improves Health-Related Quality of Life in Crohn's Disease Patients for Whom Infliximab Treatment Was Not Successful: Results from the WELCOME Study

✍ Brian G. Feagan; William J. Sandborn; Douglas C. Wolf; Krassimir Mitchev; Corinn 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 156 KB

9 ASSESSMENT OF CERTOLIZUMAB PEGOL IN TH

9 ASSESSMENT OF CERTOLIZUMAB PEGOL IN THE TREATMENT OF CROHN'S DISEASE IN PATIENTS FOR WHOM INFLIXIMAB TREATMENT WAS NOT SUCCESSFUL: OPEN-LABEL INDUCTION PRELIMINARY RESULTS FROM THE WELCOME STUDY

✍ S. Vermeire; M.T. Abreu; G. D'Haens; J.F. Colombe; K. Mitchev; A. Raedler; R.N. 📂 Article 📅 2008 🏛 Oxford University Press ⚖ 91 KB

W1092 Maintenance of Long-Term Remission

W1092 Maintenance of Long-Term Remission in Patients with Moderately to Severely Active Crohn's Disease Treated for 3 Years with Adalimumab: Results from the Open-Label ADHERE Study

✍ Rutgeerts, Paul; Colombel, Jean-Frederic; Sandborn, William J.; Rutgeerts, Paul 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 99 KB

Long-term oncologic outcomes of 714 cons

Long-term oncologic outcomes of 714 consecutive laparoscopic gastrectomies for gastric cancer: results from the 7-year experience of a single institute

✍ Kyung Ho Pak; Woo Jin Hyung; Taeil Son; Kazutaka Obama; Yanghee Woo; Hyoung-Il K 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 342 KB